Allena Stock Probability of Future Stock Price Finishing Over 0.0

Allena Pharmaceuticals' future price is the expected price of Allena Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Allena Pharmaceuticals performance during a given time horizon utilizing its historical volatility. The current year Price to Book Value is expected to grow to 2.91, whereas Price to Earnings Ratio are forecasted to decline to (0.89) .
  
Please continue to Trending Equities.Please specify Allena Pharmaceuticals time horizon, a valid symbol (red box) and a target price (blue box) you would like Allena Pharmaceuticals odds to be computed.

Allena Pharmaceuticals Target Price Odds to finish over 0.0

The tendency of Allena Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.00 90 days 0.00 
about 87.17
Based on a normal probability distribution, the odds of Allena Pharmaceuticals to move above the current price in 90 days from now is about 87.17 (This Allena Pharmaceuticals probability density function shows the probability of Allena Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Allena Pharmaceuticals has a beta of -0.31. This suggests as returns on benchmark increase, returns on holding Allena Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, however, Allena Pharmaceuticals is likely to outperform the market. Additionally The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Allena Pharmaceuticals is significantly underperforming NYSE Composite.
   Allena Pharmaceuticals Price Density   
       Price  

Predictive Modules for Allena Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Allena Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Allena Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Allena Pharmaceuticals in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.000.0016.52
Details
Intrinsic
Valuation
LowReal ValueHigh
0.061.2717.79
Details
4 Analysts
Consensus
LowTarget PriceHigh
1.255.0611.00
Details
Earnings
Estimates (3)
LowProjected EPSHigh
-0.77-0.76-0.74
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Allena Pharmaceuticals. Your research has to be compared to or analyzed against Allena Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Allena Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Allena Pharmaceuticals.

Allena Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Allena Pharmaceuticals is not an exception. The market had few large corrections towards the Allena Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Allena Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Allena Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-3.2
β
Beta against NYSE Composite-0.31
σ
Overall volatility
0.04306
Ir
Information ratio -0.37

Allena Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Allena Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Allena Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Allena Pharmaceuticals is not yet fully synchronised with the market data
Allena Pharmaceuticals generated a negative expected return over the last 90 days
Allena Pharmaceuticals has high historical volatility and very poor performance
Allena Pharmaceuticals has some characteristics of a very speculative penny stock
Net Loss for the year was (32.84 M) with profit before overhead, payroll, taxes, and interest of 0.
Allena Pharmaceuticals currently holds about 8.89 M in cash with (45.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08.
Allena Pharmaceuticals has a frail financial position based on the latest SEC disclosures

Allena Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Allena Stock often depends not only on the future outlook of the current and potential Allena Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Allena Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding32506679.00
Cash And Short Term Investments29988000.00

Allena Pharmaceuticals Technical Analysis

Allena Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Allena Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Allena Pharmaceuticals. In general, you should focus on analyzing Allena Stock price patterns and their correlations with different microeconomic environments and drivers.

Allena Pharmaceuticals Predictive Forecast Models

Allena Pharmaceuticals time-series forecasting models is one of many Allena Pharmaceuticals' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Allena Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Allena Pharmaceuticals

Checking the ongoing alerts about Allena Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Allena Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Allena Pharmaceuticals is not yet fully synchronised with the market data
Allena Pharmaceuticals generated a negative expected return over the last 90 days
Allena Pharmaceuticals has high historical volatility and very poor performance
Allena Pharmaceuticals has some characteristics of a very speculative penny stock
Net Loss for the year was (32.84 M) with profit before overhead, payroll, taxes, and interest of 0.
Allena Pharmaceuticals currently holds about 8.89 M in cash with (45.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08.
Allena Pharmaceuticals has a frail financial position based on the latest SEC disclosures
Please continue to Trending Equities. You can also try Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for analysis

When running Allena Pharmaceuticals price analysis, check to measure Allena Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allena Pharmaceuticals is operating at the current time. Most of Allena Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Allena Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Allena Pharmaceuticals' price. Additionally, you may evaluate how the addition of Allena Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Is Allena Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Allena Pharmaceuticals. If investors know Allena will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Allena Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
9.2 M
Return On Assets
(1.07) 
Return On Equity
(5.41) 
The market value of Allena Pharmaceuticals is measured differently than its book value, which is the value of Allena that is recorded on the company's balance sheet. Investors also form their own opinion of Allena Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Allena Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Allena Pharmaceuticals' market value can be influenced by many factors that don't directly affect Allena Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Allena Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Allena Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Allena Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.